| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 St. Marianna University School of Medicine, Kawasaki 216-8511, Japan and
2 Department of Cell Molecular Physiology
3 Mental Health Neuroscience Clinical Research Center, School of Medicine University of North Carolina, Chapel Hill, NC 27599
Despite great progress in basic schizophrenia research, the conclusive identification of specific etiological factors or pathogenic processes in the illness has remained elusive. The convergence of modern neuroscientific studies in molecular genetics, molecular neuropathology, neurophysiology, in vivo brain imaging, and psychopharmacology, however, indicates that we may be coming much closer to understanding the molecular basis of schizophrenia. Schizophrenia may be a neurodevelopmental and progressive disorder with multiple biochemical abnormalities involving the dopaminergic, serotonin, glutamate, and 
-aminobutyric acidergic systems. In the near future, biological markers for the illness may come from the combination of diverse assessment techniques. An understanding of the pathophysiology of schizophrenia will be essential to the discovery of preventive measures and therapeutic intervention. Rapidly advancing research into schizophrenia includes diverse etiological hypotheses, and offers directions for future research and treatments.
Related articles in MI:
This article has been cited by other articles:
|
|
 |
|
  O. B. Kwon, D. Paredes, C. M. Gonzalez, J. Neddens, L. Hernandez, D. Vullhorst, and A. Buonanno Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors PNAS, October 7, 2008; 105(40): 15587 - 15592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jenstad, A. Z. Quazi, M. Zilberter, C. Haglerod, P. Berghuis, N. Saddique, M. Goiny, D. Buntup, S. Davanger, F.-M. S. Haug, et al. System A Transporter SAT2 Mediates Replenishment of Dendritic Glutamate Pools Controlling Retrograde Signaling by Glutamate Cereb Cortex, October 1, 2008; (2008) bhn151v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Erickson, J. R. Ciccone, S. B. Schwarzkopf, J. S. Lamberti, and M. J. Vitacco Legal Fallacies of Antipsychotic Drugs J Am Acad Psychiatry Law, June 1, 2007; 35(2): 235 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-J. Gao Acute Clozapine Suppresses Synchronized Pyramidal Synaptic Network Activity by Increasing Inhibition in the Ferret Prefrontal Cortex J Neurophysiol, February 1, 2007; 97(2): 1196 - 1208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Braff, R. Freedman, N. J. Schork, and I. I. Gottesman Deconstructing Schizophrenia: An Overview of the Use of Endophenotypes in Order to Understand a Complex Disorder Schizophr Bull, January 1, 2007; 33(1): 21 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. Roberts, T. D. Warner, K. G. Hammond, and L. B. Dunn Assessments by Patients With Schizophrenia and Psychiatrists of Relative Risk of Research Procedures Psychiatr Serv, November 1, 2006; 57(11): 1629 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Buckley, D. Dean, F. L. Bookstein, S. Han, M. Yerukhimovich, K.-J. Min, and B. Singer A Three-Dimensional Morphometric Study of Craniofacial Shape in Schizophrenia Am J Psychiatry, March 1, 2005; 162(3): 606 - 608. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |
